CRNT
Ceragon Networks Ltd.
CRNT's outlook is improving, though it still trails on the overall score.
MSFT
Microsoft Corporation
MSFT has the edge over CRNT overall, supported by stronger fundamentals and stronger valuation.
CRNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
CRNT's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CRNT PE Valuation
CRNT has no meaningful PE right now: it lost money over the past year.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
CRNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
CRNT has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
CRNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.14 | — |
| Q2 2026 | -$0.04 | -125% |
| Q1 2026 | -$0.03 | -112% |
| Q4 2025 | -$0.02 | -107% |
| Q3 2025 | $0.02 | -91% |
| Q2 2025 | $0.16 | +33% |
| Q1 2025 | $0.26 | +420% |
| Q4 2024 | $0.27 | +286% |
| Q3 2024 | $0.22 | +340% |
CRNT has swung to a loss: it lost $0.04 per share over the past year, after a profit the year before.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over CRNT on earnings quality, reporting a profit while its opponent remains loss making.
CRNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $93.9M | +14% |
| Q1 2026 | $85M | -4.1% |
| Q4 2025 | $82.3M | -23% |
| Q3 2025 | $85.5M | -17% |
| Q2 2025 | $82.3M | -14% |
| Q1 2025 | $88.7M | +0.2% |
| Q4 2024 | $106.9M | +18% |
| Q3 2024 | $102.7M | +18% |
CRNT's revenue is down over the past year, though its latest quarter was up: $94M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.3% | -2.7 points |
| Q1 2026 | 2.5% | +3.7 points |
| Q4 2025 | 2.1% | -6.8 points |
| Q3 2025 | 4.4% | -9.9 points |
| Q2 2025 | 3% | -7.8 points |
| Q1 2025 | -1.2% | -6 points |
| Q4 2024 | 8.9% | +4.3 points |
| Q3 2024 | 14% | +6.6 points |
CRNT's operating margin was 0.3% last quarter, down 2.7 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over CRNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over CRNT on profitability, with a higher operating margin.
CRNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.7M | -69% |
| Q1 2026 | $2.8M | +$4.2M |
| Q4 2025 | $8.6M | +$11.9M |
| Q3 2025 | $4.4M | -58% |
| Q2 2025 | $5.6M | +$6M |
| Q1 2025 | -$1.4M | -150% |
| Q4 2024 | -$3.2M | -142% |
| Q3 2024 | $10.6M | -2.6% |
CRNT has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
CRNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +325K shares |
| 1 year | +1.7% | +1.6M shares |
| 3 years | +6.7% | +5.7M shares |
| 5 years | +9.1% | +7.6M shares |
| Available history | +11% | +9.4M shares |
CRNT has 91M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CRNT hasn't bought back shares in the past year.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over CRNT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
CRNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | 0.2x | Very low |
CRNT has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
CRNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.9 | Neutral |
| Stochastic | 59.2 | Neutral |
CRNT's weekly RSI is 57 (neutral) and its Stochastic is 59 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
CRNT PE vs Technology Sector
| Metric | CRNT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CRNT has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
CRNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.15 | 11% above |
| 20 week MA | $2.16 | 10% above |
| 50 week MA | $2.29 | 3.9% above |
| 100 week MA | $2.50 | 4.8% below |
| 200 week MA | $2.44 | 2.5% below |
CRNT has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 2.5% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over CRNT on trend strength, trading above more of its moving averages.
CRNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.06 | $2.86 | +39% |
| 2021 | $2.86 | $2.64 | -7.7% |
| 2022 | $2.64 | $1.90 | -28% |
| 2023 | $1.90 | $2.16 | +14% |
| 2024 | $2.16 | $4.71 | +118% |
| 2025 | $4.71 | $2.11 | -55% |
| 2026 YTD | $2.11 | $2.38 | +13% |
CRNT has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.